tirzepatide and reflux vs. Semaglutide: What You Should Know Retatrutide vs Tirzepatide (2026): Differences

It is also widely prescribed by specialist physicians off-label for adults with obesity (BMI 30+) or overweight (BMI 27+) with weight-related conditions such as high blood pressure, high cholesterol, or insulin resistance, where medically supervised GLP-1 therapy is indicated

Survivorship bias happens when the accounts you see are not representative of all experiences but are disproportionately skewed toward the most remarkable, positive cases

On average, people in the study were over age 65, more than 70% were White, and more than 92% were men, so the study results may not apply to other types of GLP-1 users

Foundayo is off to an okay-ish start with 3,707 prescriptions in its first two weeks of launch, compared to oral Wegovys 18,410 prescriptions